Ebola Vaccine: How Far are we?

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 5

Abstract

Ebola viruses have been identified as an emerging threat as it causes severe haemorrhagic fever in human with mortality rates ranging from 50 to 90%. In addition to being a global health concern, the virus also is considered a potential biological threat agent. As for now, no licensed vaccine is available for pre or post exposure treatment. Recent epidemic of this disease in South Africa has led to concern towards development of an effective vaccine on a priority basis. This review is an attempt to look upon current progress in the development of Ebola virus vaccines and highlights strategies that have the greatest potential for commercial development.

Authors and Affiliations

Rajani Sharma, Ketki Jangid, Dr. Anuradha

Keywords

Related Articles

Root Conditioning with Citric Acid and Ethylenediaminetetraacetic Acid and their Effect on Fibrin Clot Adhesion to Dentin-A Scanning Electron Microscopic Study

Introduction: Root biomodifiers are used to remove the smear layer formed on the roots as a result of mechanical debridement and also to expose collagen fibers making the root surfaces biologically acceptable. Further, t...

Awareness of Yemeni Paediatricians and Other Physicians about the International Malaria Management Guidelines in the Major Public Hospitals in Sanaa, Yemen

ABSTRACT Introduction: Malaria still represents a substantial morbidity burden in the developing countries including Yemen. Keeping updated with the latest evidence-based prevention and treatment guidelines will improve...

Prevention of Parent to Child Transmission of HIV: Single Centre Experience of 14 years at Tertiary Care Hospital in Delhi, India

Introduction: Prevention of Parent To Child Transmission (PPTCT) of HIV/AIDS is an integral component of AIDS control programme. PPTCT is an ongoing programme since last 15 years. Aim: The aim of the study was to evaluat...

Children’s Physical Activity Awareness among Mothers in a Saudi Arabian Health Center

Introduction: Physical inactivity is a major contributor to the increasing levels of obesity and other serious medical conditions among children and adolescents worldwide. A major factor in this increase is lack of aware...

Linezolid and Vancomycin Resistant Enterococci: A Therapeutic Problem

Introduction: Enterococci are recognized as opportunistic pathogens, as well as commensals in both humans and animals. They are an important cause of nosocomial infections, difficult to treat, as the organism have intrin...

Download PDF file
  • EP ID EP341305
  • DOI 10.7860/JCDR/2017/22184.9863
  • Views 84
  • Downloads 0

How To Cite

Rajani Sharma, Ketki Jangid, Dr. Anuradha (2017). Ebola Vaccine: How Far are we?. Journal of Clinical and Diagnostic Research, 11(5), 1-4. https://europub.co.uk/articles/-A-341305